StockData
OS Therapies Inc logo

OS Therapies Inc (OSTX) stock

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.74−0.01 (-0.68%)

Close on Nov 13, 2026Market cap $34.36MP/E –Yield –

OS Therapies enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

OS Therapies's enterprise value was $39.29M on Nov 11, 2026, against $57.68M a year earlier. Over the last 2 years it ranged from $15.85M to $88.80M, with a median of $52.06M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$39.29M-12.1%
2025Dec 31, 2025$44.70M-49.7%
2024Dec 31, 2024$88.80M–

More OS Therapies figures

See a number that looks wrong?